1st Quarter - Report · 2026

Filing UUID: 46e354ed-20c9-4852-858d-b68eb3eac221
Type: Q1 — 1st Quarter - Report
Period: first_quarter
Year: 2026
Posted: 2026-04-17 18:06:28
Income (reported): —
Expenses (reported): —
Filing document: Open on lda.senate.gov

Registrant (lobbying firm)

VAN SCOYOC ASSOCIATES

Government Relations Consultant

Contact: H. STEWART VAN SCOYOC
Phone: +1 202-638-1950
Address: zip:20024, city:Washington, state:DC, street:800 Maine Avenue, SW Suite 800

Client

NEUROFIBROMATOSIS, INC. MIDWEST

Advocacy and research organization

State: IL
Country: US
Government-entity client: false
Effective date: 2009-01-08

Issues lobbied + lobbyists

`BUD` — Budget/Appropriations

Medical research issues and Neurofibromatosis provisions, as follows: Public Law 119-75, Consolidated Appropriations Act, 2026, Division A - Department of Defense Appropriations Act, 2026; and Division B - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 Department of Defense Appropriations Act, 2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027

Lobbyists: KATHERINE VANLANDINGHAM

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

`DEF` — Defense